Katharina Lins is a seasoned Medical Director at Pfizer Ltd., where she excels as the Global Medical Affairs Lead and European Medical Director for a heart failure product and a broader cardiovascular (CV) portfolio. With extensive international experience in medical affairs and clinical research, Katharina...
Katharina Lins is a seasoned Medical Director at Pfizer Ltd., where she excels as the Global Medical Affairs Lead and European Medical Director for a heart failure product and a broader cardiovascular (CV) portfolio. With extensive international experience in medical affairs and clinical research, Katharina has honed her expertise in primary care, focusing on innovative strategies that prioritize patient outcomes. Her role encompasses the strategic planning and operational implementation of global products, ensuring that every initiative is aligned with both market needs and patient care objectives.
In her capacity as Global Medical Affairs Lead, Katharina collaborates closely with regional and country teams to optimize Pfizer's market positioning, ensuring that the company’s products resonate with healthcare professionals and patients alike. Her ability to navigate complex cross-functional governance bodies allows her to represent medical affairs effectively, advocating for evidence-based practices and fostering a culture of collaboration across departments.
Katharina's analytical thinking and business acumen are instrumental in driving key projects that enhance the therapeutic landscape for cardiovascular diseases. Her expertise spans various therapeutic areas, including central nervous system (CNS) disorders and pain management, making her a versatile leader in the pharmaceutical industry. By leveraging her skills in clinical trials and international medical affairs, Katharina continues to contribute significantly to Pfizer's mission of delivering innovative healthcare solutions that improve patient lives.
